Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is O  [Clear All Filters]
2019
Candoni, A., Rambaldi, A., Fanin, R., Velardi, A., Arcese, W., Ciceri, F., Lazzarotto, D., Lussana, F., Olivieri, J., Grillo, G., et al. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Societ.Biol Blood Marrow Transplant.
Chaudhry, Q.Un Nisa, Iftikhar, R., Satti, T.Mehmood, Mahmood, S.Kamran, Ghafoor, T., Shamshad, G.Umair, Shahbaz, N., Khan, M.Ali, Khattak, T.Azam, Rehman, J., et al. (2019). Outcome of Fludarabine Based Conditioning in High Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single Center Study from Pakistan.Biol Blood Marrow Transplant.
Hill-Kayser, C.E., Tochner, Z., Li, Y., Kurtz, G., Lustig, R.A., James, P., Balamuth, N., Womer, R., Mattei, P., Grupp, S., et al. (2019). Outcomes after Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma.Int J Radiat Oncol Biol Phys.
Marks, D.I., Kebriaei, P., Stelljes, M., Gökbuget, N., Kantarjian, H., Advani, A.S., Merchant, A., Stock, W., Cassaday, R.D., Wang, T., et al. (2019). Outcomes of allogeneic stem cell transplantation after inotuzumab ozogamicin treatment for relapsed or refractory acute lymphoblastic leukemia.Biol Blood Marrow Transplant.
Sanders, S., Chua, N., Larouche, J.-F., Owen, C., Shafey, M., and Stewart, D.A. (2019). Outcomes of Consecutively Diagnosed Primary Central Nervous System Lymphoma Patients Using the Alberta Lymphoma Clinical Practice Guideline Incorporating Thiotepa-Busulfan Conditioning for Transplant-Eligible Patients.Biol Blood Marrow Transplant.
Halder, R., Mishra, P., Dhawan, R., Aggarwal, M., Seth, T., Mahapatra, M., and Saxena, R. (2019). Outcomes of paroxysmal nocturnal hemoglobinuria in the pediatric age group in a resource-constrained setting.Pediatr Blood Cancere27712.
Hatina, J., Boesch, M., Sopper, S., Kripnerova, M., Wolf, D., Reimer, D., Marth, C., and Zeimet, A.G. (2019). Ovarian Cancer Stem Cell Heterogeneity.Adv Exp Med Biol1139, 201-221.
Su, Y.-K., Bamodu, O.Adebayo, Tzeng, Y.-M., Hsiao, M., Yeh, C.-T., and Lin, C.-M. (2019). Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide.Phytomedicine61, 152840.
Xiang, J., Ding, Y., Li, J., Zhao, X., Sun, Y., Wang, D., Wang, L., and Chen, Y. (2019). Ovatodiolides: Scalable Protection-free Syntheses, Configuration Determination and Biological Evaluation against Hepatic Cancer Stem Cells.Angew Chem Int Ed Engl.
Kawai, H., Matsushita, H., Suzuki, R., Kitamura, Y., Ogawa, Y., Kawada, H., and Ando, K. (2019). Overcoming Tyrosine Kinase Inhibitor Resistance in Transformed Cell Harboring SEPT9-ABL1 Chimeric Fusion Protein.Neoplasia21, 788-801.
Yu, K., Wang, J., Lu, T., Ma, D., Wei, D., Guo, Y., Cheng, B., Wang, W., and Fang, Q. (2019). Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion.J Cell Biochem.
Lu, C., Shi, X., Allen, A., Baez-Nieto, D., Nikish, A., Sanjana, N.E., and Pan, J.Q. (2019). Overexpression of NEUROG2 and NEUROG1 in human embryonic stem cells produces a network of excitatory and inhibitory neurons.Faseb Jfj201801110RR.
Wu, H.Fu, and Zeltner, N. (2019). Overview of Methods to Differentiate Sympathetic Neurons from Human Pluripotent Stem Cells.Curr Protoc Stem Cell Biol50, e92.
Stojanovska, V., Prakash, M., McQuade, R., Fraser, S., Apostolopoulos, V., Sakkal, S., and Nurgali, K. (2019). Oxaliplatin Treatment Alters Systemic Immune Responses.Biomed Res Int2019, 4650695.
Perikamana, S.Kumar Madh, Lee, S.Min, Lee, J., Ahmad, T., Lee, M., Yang, H.-S., and Shin, H. (2019). Oxidative Epigallocatechin Gallate Coating on Polymeric Substrates for Bone Tissue Regeneration.Macromol Bioscie1800392.
Sheikhansari, G., Soltani-Zangbar, M.Sadegh, Pourmoghadam, Z., Kamrani, A., Azizi, R., Aghebati-Maleki, L., Danaii, S., Koushaeian, L., Hojat-Farsangi, M., and Yousefi, M. (2019). Oxidative stress, inflammatory settings, and microRNA regulation in the recurrent implantation failure patients with metabolic syndrome.Am J Reprod Immunole13170.
Klontzas, M.E., Reakasame, S., Silva, R., Morais, J.C.F., Vernardis, S., MacFarlane, R.J., Heliotis, M., Tsiridis, E., Panoskaltsis, N., Boccaccini, A.R., et al. (2019). Oxidized alginate hydrogels with the GHK peptide enhance cord blood mesenchymal stem cell osteogenesis: a paradigm for metabolomics-based evaluation of biomaterial design.Acta Biomater.
Papas, K.K., De Leon, H., Suszynski, T.M., and Johnson, R.C. (2019). Oxygenation strategies for encapsulated islet and beta cell transplants.Adv Drug Deliv Rev.
2018
Nichane, M., and Loh, K.M. (2018). Obliterating Obstacles to an Odyssey.Cell Stem Cell23, 313-315.
Monroy, E.Alonso Cru, Santos, P.Paulo de A., Lopes, M.Luiza Dini, Mosqueda-Taylor, A., Pinto, L.Pereira, and de Souza, L.Batista (2018). Oct-4 and CD44 in epithelial stem cells like of benign odontogenic lesions.Histochem Cell Biol.
Felder-Schmittbuhl, M.-P., Buhr, E.D., Dkhissi-Benyahya, O., Hicks, D., Peirson, S.N., Ribelayga, C.P., Sandu, C., Spessert, R., and Tosini, G. (2018). Ocular Clocks: Adapting Mechanisms for Eye Functions and Health.Invest Ophthalmol Vis Sci59, 4856-4870.
Inamoto, Y., Valdés-Sanz, N., Ogawa, Y., Alves, M., Berchicci, L., Galvin, J., Greinix, H., Hale, G.A., Horn, B., Kelly, D., et al. (2018). Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.Biol Blood Marrow Transplant.
Yamagami, S., Yokoo, S., and Sakimoto, T. (2018). Ocular Surface Reconstruction with the Autologous Conjunctival Epithelium and Establishment of a Feeder-free and Serum-free Culture System.Cornea.
Stumm, J., Vallecillo-García, P., Hofe-Schneider, S.Vom, Ollitrault, D., Schrewe, H., Economides, A.N., Marazzi, G., Sassoon, D.A., and Stricker, S. (2018). Odd skipped-related 1 (Osr1) identifies muscle-interstitial fibro-adipogenic progenitors (FAPs) activated by acute injury.Stem Cell Res32, 8-16.
Law, L., Hunt, C.L., van Wijnen, A.J., Nassr, A., A Larson, N., Eldrige, J.S., Mauck, W.D., Pingree, M.J., Yang, J., Muir, C.W., et al. (2018). Office-Based Mesenchymal Stem Cell Therapy for the Treatment of Musculoskeletal Disease: A Systematic Review of Recent Human Studies.Pain Med.

Pages